Review
Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development
Affiliations
- PMID: 7958483
Item in Clipboard
Review
Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development
Dev Biol Stand.
1994.
Abstract
Vaccinia virus, effectively used for immunization against smallpox, now serves as a recombinant vector for the development of vaccines against other infectious agents and cancer. Recent advances have led to increased gene expression, enhanced immunogenicity, and greater safety. Both replicating and host-restricted non-replicating vectors are available.
Similar articles
-
Safe and effective poxvirus vectors--NYVAC and ALVAC.Dev Biol Stand. 1994;82:65-9. Dev Biol Stand. 1994. PMID: 7958484 Review.
-
Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.J Virol. 2002 Aug;76(15):7713-23. doi: 10.1128/jvi.76.15.7713-7723.2002. J Virol. 2002. PMID: 12097585 Free PMC article.
-
[Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].Rev Argent Microbiol. 2007 Jul-Sep;39(3):138-42. Rev Argent Microbiol. 2007. PMID: 17987847 Spanish.
-
Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.Prog Vet Microbiol Immunol. 1988;4:197-217. Prog Vet Microbiol Immunol. 1988. PMID: 3078866 Review.
-
Viral vector systems for gene therapy.Cancer Gene Ther. 1994 Mar;1(1):51-64. Cancer Gene Ther. 1994. PMID: 7621239 Review. No abstract available.
Cited by
-
Recombinant vaccinia viruses. Design, generation, and isolation.Mol Biotechnol. 1999 Dec 15;13(3):223-45. doi: 10.1385/MB:13:3:223. Mol Biotechnol. 1999. PMID: 10934535
-
Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.J Virol. 2007 Jul;81(13):7022-33. doi: 10.1128/JVI.02654-06. Epub 2007 Apr 4. J Virol. 2007. PMID: 17409140 Free PMC article.
-
Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases.Ann Surg. 1999 Sep;230(3):352-60; discussion 360-1. doi: 10.1097/00000658-199909000-00008. Ann Surg. 1999. PMID: 10493482 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources